These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30423128)

  • 21. In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites.
    Jiménez-Meléndez A; Ojo KK; Wallace AM; Smith TR; Hemphill A; Balmer V; Regidor-Cerrillo J; Ortega-Mora LM; Hehl AB; Fan E; Maly DJ; Van Voorhis WC; Álvarez-García G
    Int J Parasitol; 2017 Oct; 47(12):811-821. PubMed ID: 28899692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
    Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the bumped kinase inhibitor BKI-1708 against the cyst-forming apicomplexan parasites Toxoplasma gondii and Neospora caninum in vitro and in experimentally infected mice.
    de Sousa MCF; Imhof D; Hänggeli KPA; Choi R; Hulverson MA; Arnold SLM; Van Voorhis WC; Fan E; Roberto SS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2024 Jun; 25():100553. PubMed ID: 38917582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrimethamine concentrations in serum during treatment of acute murine experimental toxoplasmosis.
    Weiss LM; Luft BJ; Tanowitz HB; Wittner M
    Am J Trop Med Hyg; 1992 Mar; 46(3):288-91. PubMed ID: 1558268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity.
    Zhang LH; Jin LL; Liu F; Jin C; Jin CM; Wei ZY
    Exp Parasitol; 2020 Sep; 216():107935. PubMed ID: 32569599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis.
    Moine E; Moiré N; Dimier-Poisson I; Brunet K; Couet W; Colas C; Van Langendonck N; Enguehard-Gueiffier C; Gueiffier A; Héraut B; Denevault-Sabourin C; Debierre-Grockiego F
    Int J Parasitol; 2018 Jun; 48(7):561-568. PubMed ID: 29524527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of potential Toxoplasma gondii CDPK1 inhibitors with new scaffolds based on the combination of QSAR and scaffold-hopping method with in vitro validation.
    Zhang P; Jia L; Tian Y; Xi L; Duan R; Chen X; Xiao J; Yao X; Lan J; Li S
    Chem Biol Drug Des; 2020 May; 95(5):476-484. PubMed ID: 31436911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts.
    Doggett JS; Schultz T; Miller AJ; Bruzual I; Pou S; Winter R; Dodean R; Zakharov LN; Nilsen A; Riscoe MK; Carruthers VB
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.
    Vidadala RS; Rivas KL; Ojo KK; Hulverson MA; Zambriski JA; Bruzual I; Schultz TL; Huang W; Zhang Z; Scheele S; DeRocher AE; Choi R; Barrett LK; Siddaramaiah LK; Hol WG; Fan E; Merritt EA; Parsons M; Freiberg G; Marsh K; Kempf DJ; Carruthers VB; Isoherranen N; Doggett JS; Van Voorhis WC; Maly DJ
    J Med Chem; 2016 Jul; 59(13):6531-46. PubMed ID: 27309760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.
    Shubar HM; Lachenmaier S; Heimesaat MM; Lohman U; Mauludin R; Mueller RH; Fitzner R; Borner K; Liesenfeld O
    J Drug Target; 2011 Feb; 19(2):114-24. PubMed ID: 20367080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
    Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
    J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in
    Müller J; Anghel N; Imhof D; Hänggeli K; Uldry AC; Braga-Lagache S; Heller M; Ojo KK; Ortega-Mora LM; Van Voorhis WC; Hemphill A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216497
    [No Abstract]   [Full Text] [Related]  

  • 33. Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis.
    Lapinskas PJ; Ben-Harari RR
    Postgrad Med; 2019 Nov; 131(8):589-596. PubMed ID: 31399001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
    Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single mutation in the gatekeeper residue in TgMAPKL-1 restores the inhibitory effect of a bumped kinase inhibitor on the cell cycle.
    Sugi T; Kawazu S; Horimoto T; Kato K
    Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):1-8. PubMed ID: 25941623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of protective immunity induced by recombinant calcium-dependent protein kinase 1 (TgCDPK1) protein against acute toxoplasmosis in mice.
    Huang SY; Chen K; Wang JL; Yang B; Zhu XQ
    Microb Pathog; 2019 Aug; 133():103560. PubMed ID: 31145981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
    Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
    Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo activity of piritrexim [corrected] against Toxoplasma gondii.
    Araujo FG; Guptill DR; Remington JS
    J Infect Dis; 1987 Nov; 156(5):828-30. PubMed ID: 3484324
    [No Abstract]   [Full Text] [Related]  

  • 40. Bumped kinase inhibitor prohibits egression in Babesia bovis.
    Pedroni MJ; Vidadala RS; Choi R; Keyloun KR; Reid MC; Murphy RC; Barrett LK; Van Voorhis WC; Maly DJ; Ojo KK; Lau AO
    Vet Parasitol; 2016 Jan; 215():22-8. PubMed ID: 26790733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.